Palovarotene 5 mg, 10 mg Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 5 mg, 10 mg
Reference Brands: Sohonos (USA/EU)
Category: Orphan Drugs
Palovarotene is a Orphan Drugs product available as Capsules in strengths 5 mg, 10 mg. It corresponds to the reference brand Sohonos (USA/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Palovarotene, marketed under the brand name Sohonos, is an oral medication indicated for the treatment of heterotopic ossification and fibrodysplasia ossificans progressiva (FOP), a rare genetic disorder that causes abnormal bone formation in muscles, tendons, and ligaments. As a highly selective retinoic acid receptor gamma (RARγ) agonist, palovarotene works by inhibiting the signaling pathways that lead to unwanted bone growth, helping to slow disease progression and preserve mobility.
Taken orally, Sohonos offers a targeted therapeutic option for patients suffering from FOP, a debilitating condition that severely impacts movement and quality of life. By addressing the underlying mechanism of abnormal bone formation, palovarotene provides hope for improved patient outcomes in a condition with limited treatment options. Its development as an orphan drug highlights its role in managing rare and serious skeletal disorders.
Palovarotene — third party manufacturing & bulk supply
Palovarotene 5 mg, 10 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Palovarotene listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Palovarotene →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Palovarotene is used for the treatment of fibrodysplasia ossificans progressiva (FOP), a rare genetic disorder that causes abnormal bone formation.
Palovarotene is a chemically synthesized selective retinoic acid receptor gamma (RARγ) agonist designed to inhibit heterotopic ossification.
The trade name of Palovarotene is Sohonos.
Palovarotene (Sohonos) is developed and marketed by Clementia Pharmaceuticals (a wholly-owned subsidiary of Ipsen).
The generic name of Sohonos is Palovarotene.
The brand name is Sohonos.
Palovarotene is manufactured at Ipsen-approved facilities under international GMP and regulatory standards.
Related Products
Pasireotide Diaspartate
Strength:
0.3 mg/mL, 0.6 mg/mL, 1.2 mg/mL, 10 mg, 20 mg, 30 mg
Form: Injection
Reference Brands: Signifor (USA/EU)
View Details
Sepiapterin
Strength:
1000 mg, 250 mg
Form: Tablets / oral powder
Reference Brands: Sephience (USA/EU)
View Details
Glycerol Phenylbutyrate
Strength:
1.1 g/mL
Form: Oral Solution
Reference Brands: Ravicti (USA)
View Details
Lumasiran Sodium
Strength:
94.5 mg/0.5 mL
Form: Injection
Reference Brands: Oxlumo (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
